Azione ENZY ENZYMOTEC LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati
Strumento inattivo

Altre lingue Enzymotec Ltd.

Azioni

ENZY

IL0011296188

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Aker Biomarine Antarctic AS acquired Krill Oil Business of Enzymotec Ltd. for $26.4 million.
Enzymotec Ltd.(NasdaqGS:ENZY) dropped from NASDAQ Composite Index
Frutarom Ltd. completed the acquisition of the remaining 81.3% stake in Enzymotec Ltd. from Paulson & Co. Inc. and others for approximately $230 million.
Enzymotec Shareholders Approve Proposed Acquisition by Frutarom
Enzymotec Ltd. Reports Third Quarter 2017 Unaudited Financial Results
Enzymotec Ltd. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017
Enzymotec Ltd. Calls 2017 Annual and Extraordinary General Meeting of Shareholders for Approval of Merger and Other Matters
Enzymotec Ltd. Announces Signed A Definitive Agreement with Frutarom Industries Ltd
Enzymotec Enters Definitive Agreement to be Acquired by Frutarom
Enzymotec Ltd.(NasdaqGS:ENZY) dropped from S&P Global BMI Index
Enzymotec Ltd. Expands VAYA Product Portfolio with Five Nutritional Supplements Acquired from Union Springs Healthcare
Enzymotec Ltd. acquired five nutritional supplements from Union Springs Healthcare, LLC for $27.9 million.
Enzymotec Ltd. Responds to Unsolicited Proposal from Frutarom Ltd.
Frutarom Ltd. acquired an additional 9.2% stake in Enzymotec Ltd. from Paulson & Co. Inc. for $24.2 million.
Frutarom Industries Ltd. made an offer to acquire the remaining 81.3% stake in Enzymotec Ltd. from Paulson & Co. Inc. and others for approximately $220 million.
Enzymotec Ltd. Reports Second Quarter 2017 Unaudited Financial Results
Enzymotec Ltd. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017
Enzymotec Ltd. Announces Appointment of Dror Israel as Chief Financial Officer
Enzymotec Ltd. Appoints Dror Israel as Vice President and Chief Financial Officer, Effective August 7, 2017
Enzymotec to Report Second Quarter 2017 Financial Results
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione ENZY
  4. Notizie Enzymotec Ltd.
  5. Altre lingue